Recombinant Rat RARS2 Protein，His

RARS2 (Arginyl-tRNA Synthetase 2) is a crucial enzyme in the mitochondrial protein synthesis pathway, responsible for the charging of tRNA molecules with the amino acid arginine. Mutations in the RARS2 gene have been linked to a spectrum of mitochondrial disorders, including neurodegenerative diseases and myopathies, highlighting its significance in maintaining mitochondrial function and cellular health. Research has identified RARS2 as a vital component in the unfolded protein response, which is essential for mitigating mitochondrial stress and maintaining proteostasis. Furthermore, abnormal levels of RARS2 have been observed in various cancers, suggesting its potential role in tumorigenesis and metabolic regulation. The reconstitution of RARS2 proteins has become a focal point for understanding mitochondrial disease mechanisms, exploring therapeutic avenues, and developing novel diagnostic tools. As researchers investigate the structural and functional characteristics of RARS2, they aim to elucidate its interactions with other mitochondrial and cytoplasmic components, as well as assess how different mutations impact its activity. This line of inquiry not only aids in comprehending the molecular underpinnings of associated diseases but also opens pathways for innovative therapeutic strategies targeting mitochondrial dysfunction. Overall, the study of RARS2 recombinant proteins exemplifies the intricate relationship between mitochondrial biology and human health, underscoring the importance of continued research in this area to enhance our understanding of mitochondrial diseases.